Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of ursodeoxycholic acid (UDCA) in serum and bile in early-stage primary biliary cirrhosis and healthy volunteers
2006-003712-22Phase 4Completed
- Sponsor
- Dr. Falk Pharma GmbH
- Start
- Sep 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ursodeoxycholic acid in primary biliary cholangitis (PBC) (2 arms), sponsored by Dr. Falk Pharma GmbH. Primary endpoint: Pharmacokinetic parameters in serum and bile. Started Sep 2006; status: completed.
02
Drugs
ursodeoxycholic acid
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on 2006-003712-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003712-22.